Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097744 · ClinicalTrials.gov registry record
Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 23
- Enrollment target
NCT03097744: Completed study, sponsored by Smith & Nephew.
NCT03097744 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03097744 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This is a retrospective study of meniscal tear repairs at least one-year post repair status. All patients were treated with Ceterix NovoStitch devices. The primary objectives of this study are to assess the clinical repair success rate via reoperation and PROs at greater than 12 months.
Primary Outcome
Data provided by patients
Interventions
- DEVICE Ceterix NovoStitch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2018-04-20 |
What the finished NCT03097744 record still lists
NCT03097744 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ceterix NovoStitch is the first listed.
NCT03097744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03097744 about?
NCT03097744 is a clinical study titled "Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs". This is a retrospective study of meniscal tear repairs at least one-year post repair status. All patients were treated with Ceterix NovoStitch devices. The primary objectives of this study are to assess the clinical repair success rate via reoperation and PROs at greater than 12 months.
What is the current status of trial NCT03097744?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2017-02-01. Estimated completion is 2018-04-20.
What interventions are being tested in trial NCT03097744?
The interventions under investigation include: Ceterix NovoStitch (DEVICE).
Who is sponsoring clinical trial NCT03097744?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI